Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP)
CUSIP: 890260839
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 13,418,426
- Total 13F shares
- 5,377
- Share change
- +5,377
- Total reported value
- $1,773
- Price per share
- $0.33
- Number of holders
- 2
- Value change
- +$1,773
- Number of buys
- 2
Quarterly Holders Quick Answers
What is CUSIP 890260839?
CUSIP 890260839 identifies TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q1 2025
Recent filing periods for CUSIP 890260839:
Top shareholders of TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13D/G
|
— |
0.7%
|
1,306,313
|
$143,694 | $0 | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
361,445
|
$53,675 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
240,300
|
$35,564 | — | 30 Sep 2024 | |
| Virtu Financial LLC |
13F
|
Company |
—
class O/S missing
|
136,235
|
$20,000 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
115,987
|
$17,224 | — | 30 Sep 2024 | |
| Daniel Wintner Goodman |
3/4/5
|
Director |
—
class O/S missing
|
5,001
|
$8,552 | — | 25 May 2021 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
—
class O/S missing
|
40,540
|
$6,000 | — | 30 Sep 2024 | |
| Marex Group plc |
13F
|
Company |
—
class O/S missing
|
37,800
|
$5,613 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
35,602
|
$5,305 | — | 30 Sep 2024 | |
| LPL Financial LLC |
13F
|
Company |
—
class O/S missing
|
30,049
|
$4,462 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
class O/S missing
|
27,563
|
$4,093 | — | 30 Sep 2024 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
—
class O/S missing
|
15,203
|
$2,258 | — | 30 Sep 2024 | |
| Jump Financial, LLC |
13F
|
Company |
—
class O/S missing
|
11,164
|
$1,658 | — | 30 Sep 2024 | |
| MRP Capital Investments, LLC |
13F
|
Company |
—
class O/S missing
|
10,000
|
$1,485 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
—
class O/S missing
|
789
|
$117 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
249
|
$37 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
180
|
$27 | — | 30 Sep 2024 | |
| DANSKE BANK A/S |
13F
|
Company |
—
class O/S missing
|
14
|
$2 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
—
class O/S missing
|
10
|
$1 | — | 30 Sep 2024 | |
| Allworth Financial LP |
13F
|
Company |
—
class O/S missing
|
1
|
$1 | — | 30 Sep 2024 | |
| CENTRAL TRUST Co |
13F
|
Company |
—
class O/S missing
|
1
|
$1 | — | 30 Sep 2024 | |
| Planning Capital Management Corp |
13F
|
Company |
—
class O/S missing
|
1
|
$1 | — | 30 Sep 2024 |
Institutional Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) as of Q4 2024
As of 31 Dec 2024,
Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,377 shares.
The largest 2 holders included
North Star Investment Management Corp. and Anchor Investment Management, LLC.
This page lists
2
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q4 2025 Across Filers
Q4 2025 holders
70
Q4 2024 holders
2
Holder diff
-68
| Investor | Q4 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.